Merck’s (NYSE:MRK) monoclonal antibody clesrovimab, designed as a prophylactic against respiratory syncytial virus (RSV), has ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

Cold and flu season — otherwise known as mid-October — is upon us. But this year, several advancements in vaccines could help ...

We are going back to the seasonal pattern of RSV we used to see before the pandemic, which typically starts during the month ...

The effectiveness of the long-acting monoclonal antibody nirsevimab (Beyfortus) against primary care visits for lower ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

WellSpan Ephrata Community Hospital is now offering respiratory syncytial virus immunizations to infants born at the hospital ...

Each year, 100,000 older US adults and 58,000 infants and children younger than 5 years are hospitalized for RSV, and 6,000 and 100 or more, respectively, die of their infections, Centers for Disease ...

Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

MOBILE, Ala. (WKRG) — More RSV cases are being reported in Mobile. It’s something you may not think much about unless you ...

First discovered in chimpanzees in 1956 and in children the following year, respiratory syncytial virus (RSV) isn’t new. Neither is it uncommon among the youngest and oldest populations ...